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Case ReportsNew 15-mL ventricular assist device in children with restrictive
physiology of the left ventricleSantosh Sundararajan, MD, Timothy Thiruchelvam, MB, ChB, Tain-Yen Hsia, MD, and
Ann Karimova, MD, London, United KingdomThe Berlin Heart Pediatric EXCOR (Berlin Heart GmbH,
Berlin, Germany) ventricular assist device (VAD) has
been successfully used as a bridge to orthotopic heart
transplant (OHT) in infants and children.1-3 The 10- and
25-mL volume pumps have improved outcomes in chil-
dren weighing less than 10 kg,2,3 although their risk of
mortality remains higher relative to larger children.3 The
risk of VAD-related complications may also be higher
when the chamber volume is not appropriately matched
to the patient size.4
Restrictive left ventricular (LV) physiology presents a
unique challenge for left VAD (LVAD) implantation in
children because of potential problems with drainage with
conventional LV apical cannulation. We describe the use
of a novel 15-mL volume Berlin Heart Pediatric EXCOR
VAD in 2 children with restrictive LV.
CLINICAL SUMMARIES
Patient 1 was a female patient, diagnosed with LV non-
compaction cardiomyopathy with restrictive features in
infancy. By 2 years, she had significant left atrial (LA)
and LV dilatation (z scores of þ9.78 and þ5.36, respec-
tively) with severe mitral regurgitation (Figure 1). Cardiac
catheterization confirmed a mean LA pressure of 44 mm
Hg and elevated pulmonary vascular resistance index of
9 Wood units/m2, decreasing to 3.2 Wood units/m2 with
inhaled nitric oxide and oxygen. At 33 months of age, after
lack of response to pharmacologic therapy on intensive
care, she was placed on extracorporeal membrane oxygen-
ation support. After 6 days on extracorporeal membrane
oxygenation support, at a weight of 9.6 kg and body surface
area of 0.48 m2, the patient underwent LVAD implantation
as bridge to OHT. A 15-mL Pediatric EXCOR pump was
implanted with LA-to-aorta cannulation because of the
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The Journal of Thoracic and Ca80 to 100 beats/min, providing a cardiac index (CI) between
2.5 and 3.1 L/min/m2. She was successfully extubated on
day 23 after LVAD implantation and remained free of
complications. After 3 months on support, the patient’s
weight had increased to 13 kg (pump rate of 120 beats/min
for a CI of 3.0 L/min/m2), and she started having sweaty
episodes on exertion. On the basis of echocardiographic
evidence of elevated LV end-diastolic volume, the pump
was upsized to 25 mL (pump rate of 80 beats/min for a CI
of 3.3 L/min/m2). After a total of 131 days of LVAD
support, the patient underwent uncomplicated OHT. She
was successfully extubated on day 3 after transplant and
discharged from intensive care on day 6.
Patient 2 was a male patient with a diagnosis of restrictive
cardiomyopathy with biventricular involvement at the age
of 11 months (weight of 10 kg and body surface area of
0.43 m2). His condition worsened during the course of
several weeks, necessitating admission to intensive care.
Echocardiography demonstrated biatrial enlargement
(z score of þ4.29) with high LV end-diastolic pressure
(17 mm Hg) on cardiac catheterization. The patient was
listed for OHT, and a 15-mL LVAD and a 15-mL right
VAD were inserted after 12 days of intensive care. LVAD
drainage was through the LA. His chest was closed on
postoperative day 6, and he was successfully extubated on
day 13. The patient has been on VAD support for 5 months,
with pump rates ranging from 85 to 115 beats/min and CIs
ranging from 2.6 to 3.5 L/min/m2, and is currently awaiting
a donor organ.DISCUSSION
Worldwide, more than half of the children supported with
the EXCORVADweigh less than 10 kg.1-3 Thewaiting time
for OHTmay be longer3 and the risk of mortality higher2 for
these smaller children. Children at the upper end of this
weight range need an estimated 1000 to 1500 mL/min of
cardiac output to decompress the LV, meet metabolic
demands, and thrive. Until recently, they have been
supported either with a 10-mL VAD, resulting in small
stroke volumes at higher pump rates, or with a 25-mL
VAD, delivering larger stroke volumes at lower pump rates
but often accompanied by lower diastolic pressure. The
consequences of such physiologic anomalies are unclear;
however, mismatch between chamber volume and body
size may contribute to VAD-related complications.4rdiovascular Surgery c Volume 147, Number 6 e79
FIGURE 1. Echocardiographic studies of patient 1 with left ventricular (LV) noncompaction cardiomyopathy before left ventricular assist device
implantation. A, Apical 4-chamber demonstrating severe left atrial (LA) dilation and pulmonary vein (PV) congestion. B, Mitral inflow Doppler trace
with short deceleration time. RA, Right atrium; RV, right ventricle; MV, mitral valve; E Vel, peak E wave velocity; DecT, deceleration time; A Vel, peak
A wave velocity; E/A ratio, ratio of peak E wave velocity to peak Awave velocity.
Case ReportsWe describe the successful use of a new 15-mL EXCOR
pump in 2 children whose requirements fell between the
ideal fill and flow characteristics of the existing pumps. In
children with a body surface area ranging from 0.33 to
0.55m2 and weight ranging from 7 to 12 kg, the 15-mL
chamber complements the EXCOR infant range. It can
achieve a CI of 2.7 to 3.3 L/min/m2 at pump rates of 60 to
120 beats/min.
Restrictive and noncompaction cardiomyopathies are rare
but contribute disproportionately to mortality in children
with cardiomyopathy.2,3,5 Conventional VAD cannulation
of the noncompliant LV often results in insufficient
drainage, with concomitant poor pump performance, and
residual LA hypertension, with subsequent pulmonary
congestion. In these patients, the LA/LV disproportion with
preservation of systolic function makes LA cannulation an
attractive option, perhaps with less risk of ventricular
thrombus formation than in dilated cardiomyopathies.From the Albany Medical Center, Albany, NY.
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and these patients could benefit most from the versatility
offered by the additional chamber size.References
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